Mass General Brigham Medicare Plan Drops Dana-Farber Cancer Institute from Network

The Public Health Impact of Medicare Advantage Network Attrition

The contract dispute between Mass General Brigham and Dana-Farber highlights a broader national trend. Seniors enrolled in Medicare Advantage plans across the country face a growing risk of losing access to their current hospitals and doctors as reimbursement disputes intensify ahead of 2027. According to reporting, federal regulators at the Centers for Medicare & Medicaid Services have proposed new rules to cushion the blow when providers exit Medicare Advantage networks, including a Special Enrollment Period designed to let affected beneficiaries switch plans without waiting for the standard open-enrollment window.

Under the proposed framework for Contract Year 2027, Medicare Advantage plans would be required to provide clearer and earlier notice when a major health system leaves a network. This regulatory adjustment aims to prevent abrupt treatment disruptions for patients currently managing complex regimens such as chemotherapy or cardiac care. For patients navigating chronic conditions or requiring specialized interventions, establishing care continuity is vital.

Prior-Authorization Denials and Institutional Financial Strain

Hospitals frequently terminate contracts when negotiated reimbursement rates fall below sustainable operating costs. Compounding this financial friction are disputes over utilization review and prior-authorization protocols. Federal watchdog findings underscore the operational strain driving these exits. According to an HHS Office of Inspector General review, 13% of prior-authorization denials in their sample met Medicare coverage rules and should have been approved. Furthermore, 18% of payment denials met coverage criteria.

The administrative burden extends into post-acute settings. A separate OIG review focusing on skilled-nursing facility admissions found that Medicare Advantage organizations overturned nearly all appealed denials for those services. Such high overturn rates indicate that initial denials often function as delay mechanisms rather than valid quality checks. For healthcare providers operating on thin margins, absorbing the costs of fighting wrongful denials while awaiting reimbursement creates direct financial pressure to walk away from restrictive contracts.

Regulatory Responses and Future Care Continuity

As contract disputes continue to reshape regional health markets, federal oversight remains a critical variable for patient stability. While CMS enforcement records track corrective-action plans and warning letters, the immediate burden falls on seniors who must navigate changing network boundaries. Patients facing sudden coverage gaps require structured guidance to identify in-network specialists and maintain uninterrupted therapeutic schedules.